160 related articles for article (PubMed ID: 22978763)
21. High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results.
Ost P; Lumen N; Goessaert AS; Fonteyne V; De Troyer B; Jacobs F; De Meerleer G
Eur Urol; 2011 Oct; 60(4):842-9. PubMed ID: 21514039
[TBL] [Abstract][Full Text] [Related]
22. Pelvic bone anatomy vs implanted gold seed marker registration for image-guided intensity modulated radiotherapy for prostate carcinoma: Comparative analysis of inter-fraction motion and toxicities.
Rastogi M; Nanda SS; Gandhi AK; Dalela D; Khurana R; Mishra SP; Srivastava A; Farzana S; Bhatt MLB; Husain N
J Egypt Natl Canc Inst; 2017 Dec; 29(4):185-190. PubMed ID: 29129577
[TBL] [Abstract][Full Text] [Related]
23. Hypofractionated Dose Escalated 3D Conformal Radiotherapy for Prostate Cancer: Outcomes from a Mono-Institutional Phase II Study.
Tramacere F; Arcangeli S; Pignatelli A; Castagna R; Portaluri M
Anticancer Res; 2015 May; 35(5):3049-54. PubMed ID: 25964594
[TBL] [Abstract][Full Text] [Related]
24. Late Genitourinary Toxicity Outcomes in 300 Prostate Cancer Patients Treated With Dose-escalated Image-guided Intensity-modulated Radiotherapy.
Byrne K; Hruby G; Kneebone A; Whalley D; Guo L; McCloud P; Eade T
Clin Oncol (R Coll Radiol); 2017 Sep; 29(9):617-625. PubMed ID: 28416260
[TBL] [Abstract][Full Text] [Related]
25. Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis.
Tamihardja J; Schortmann M; Lawrenz I; Weick S; Bratengeier K; Flentje M; Guckenberger M; Polat B
Strahlenther Onkol; 2021 Feb; 197(2):124-132. PubMed ID: 32833036
[TBL] [Abstract][Full Text] [Related]
26. Volumetric-Modulated Arc Radiotherapy with Daily Image-Guidance Carries Better Toxicity Profile for Higher Risk Prostate Cancer.
Ghanem AI; Elsaid AA; Elshaikh MA; Khedr GA
Asian Pac J Cancer Prev; 2021 Jan; 22(1):61-68. PubMed ID: 33507680
[TBL] [Abstract][Full Text] [Related]
27. A retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma.
Huang CM; Huang MY; Tsai HL; Huang CW; Ma CJ; Lin CH; Huang CJ; Wang JY
J Radiat Res; 2017 Mar; 58(2):247-259. PubMed ID: 27738080
[TBL] [Abstract][Full Text] [Related]
28. Reduced late urinary toxicity with high-dose intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer.
Zapatero A; Roch M; Büchser D; Castro P; Fernández-Banda L; Pozo G; Liñán O; Martin de Vidales C; Cruz-Conde A; García-Vicente F
Clin Transl Oncol; 2017 Sep; 19(9):1161-1167. PubMed ID: 28374321
[TBL] [Abstract][Full Text] [Related]
29. Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer.
Nath SK; Sandhu AP; Rose BS; Simpson DR; Nobiensky PD; Wang JZ; Millard F; Kane CJ; Parsons JK; Mundt AJ
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):435-41. PubMed ID: 19939580
[TBL] [Abstract][Full Text] [Related]
30. Acute gastrointestinal and genitourinary toxicity of image-guided intensity modulated radiation therapy for prostate cancer using a daily water-filled endorectal balloon.
Deville C; Both S; Bui V; Hwang WT; Tan KS; Schaer M; Tochner Z; Vapiwala N
Radiat Oncol; 2012 May; 7():76. PubMed ID: 22621764
[TBL] [Abstract][Full Text] [Related]
31. Favorable 10-year outcomes of image-guided intensity-modulated radiotherapy combined with long-term androgen deprivation for Japanese patients with nonmetastatic prostate cancer.
Tomita N; Soga N; Ogura Y; Furusawa J; Tanaka H; Koide Y; Tachibana H; Kodira T
Asia Pac J Clin Oncol; 2019 Feb; 15(1):18-25. PubMed ID: 30411504
[TBL] [Abstract][Full Text] [Related]
32. Image-guided, whole-pelvic, intensity-modulated radiotherapy for biochemical recurrence following radical prostatectomy in high-risk prostate cancer patients.
Byun SJ; Kim YS; Ahn H; Kim CS
PLoS One; 2018; 13(1):e0190479. PubMed ID: 29320570
[TBL] [Abstract][Full Text] [Related]
33. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.
Zelefsky MJ; Kollmeier M; Cox B; Fidaleo A; Sperling D; Pei X; Carver B; Coleman J; Lovelock M; Hunt M
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):125-9. PubMed ID: 22330997
[TBL] [Abstract][Full Text] [Related]
34. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes of a phase II trial of moderate hypofractionated image-guided intensity modulated radiotherapy (IG-IMRT) for localized prostate cancer.
Lieng H; Pintilie M; Bayley A; Berlin A; Bristow R; Chung P; Gospodarowicz M; Huang R; Ménard C; Warde P; Catton C
Radiother Oncol; 2017 Jan; 122(1):93-98. PubMed ID: 27838147
[TBL] [Abstract][Full Text] [Related]
36. Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy.
De Meerleer G; Fonteyne V; Meersschout S; Van den Broecke C; Villeirs G; Lumen N; Ost P; Vandecasteele K; De Neve W
Radiother Oncol; 2008 Nov; 89(2):205-13. PubMed ID: 18771809
[TBL] [Abstract][Full Text] [Related]
37. Implementation of an image guided intensity-modulated protocol for post-prostatectomy radiotherapy: planning data and acute toxicity outcomes.
Chua B; Min M; Wood M; Edwards S; Hoffmann M; Greenham S; Kovendy A; McKay MJ; Shakespeare TP
J Med Imaging Radiat Oncol; 2013 Aug; 57(4):482-9. PubMed ID: 23870349
[TBL] [Abstract][Full Text] [Related]
38. Ten-Year Outcomes of Moderately Hypofractionated (70 Gy in 28 fractions) Intensity Modulated Radiation Therapy for Localized Prostate Cancer.
Abu-Gheida I; Reddy CA; Kotecha R; Weller MA; Shah C; Kupelian PA; Mian O; Ciezki JP; Stephans KL; Tendulkar RD
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):325-333. PubMed ID: 30721720
[TBL] [Abstract][Full Text] [Related]
39. Incremental changes verses a technological quantum leap: the additional value of intensity-modulated radiotherapy beyond image-guided radiotherapy for prostate irradiation.
Ratnayake G; Martin J; Plank A; Wong W
J Med Imaging Radiat Oncol; 2014 Aug; 58(4):503-10. PubMed ID: 25243269
[TBL] [Abstract][Full Text] [Related]
40. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
Eur Urol; 2011 Dec; 60(6):1142-8. PubMed ID: 21855208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
